India cracks down on manufacturers; Vivimed says FDA OK with API plant in Spain;

> India's Drugs Control Administration issued show cause notices to 23 drug manufacturers and seized drugs from two others while inspecting 25 facilities last month. Report

> India's Vivimed Labs says its API plant in Spain successfully passed an FDA inspection. Report

> Israel-based SciVac Therapeutics says it has resumed production of its hepatitis B vaccine at a plant in British Columbia, which it earlier stopped because some vials had been damaged during labeling. Release